Fund shareholders of Sarepta Therapeutics Inc
ISIN US8036071004 · United States · LEI 549300IKDPIED8J8IG21
- Fund shareholders
- 271
- Of which ETFs
- 71 200 other funds
- Value held
- 826.2M $ 1.2M € · 7.4M SEK
- Share of capital
- 36.9 % of 105.6M shares on Jul 31, 2026
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| iShares Core S&P Small-Cap ETF iShares Trust | 6,289,013 | 136.8M $ | 0.15 % | 5.95 % | as of Mar 31, 2026 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3,384,344 | 73.6M $ | 3.24 % | 3.20 % | as of Mar 31, 2026 ↗ |
| VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS | 3,212,305 | 69.9M $ | 0.00 % | 3.04 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST | 3,057,030 | 66.5M $ | 0.89 % | 2.89 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP INDEX FUND VANGUARD INDEX FUNDS | 2,313,316 | 50.3M $ | 0.03 % | 2.19 % | as of Mar 31, 2026 ↗ |
| VANGUARD SMALL-CAP GROWTH INDEX FUND VANGUARD INDEX FUNDS | 1,292,253 | 28.1M $ | 0.07 % | 1.22 % | as of Mar 31, 2026 ↗ |
| Federated Hermes MDT Mid Cap Growth Fund Federated Hermes Equity Funds | 1,193,634 | 24.9M $ | 0.39 % | 1.13 % | as of Apr 30, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 1,169,266 | 25.4M $ | 0.03 % | 1.11 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) Portfolio S&P 600(TM) Small Cap ETF SPDR SERIES TRUST | 945,593 | 20.6M $ | 0.15 % | 0.90 % | as of Mar 31, 2026 ↗ |
| iShares Biotechnology ETF iShares Trust | 739,607 | 16.1M $ | 0.20 % | 0.70 % | as of Mar 31, 2026 ↗ |
| VANGUARD TAX-MANAGED SMALL-CAP FUND VANGUARD TAX-MANAGED FUNDS | 699,514 | 15.2M $ | 0.16 % | 0.66 % | as of Mar 31, 2026 ↗ |
| VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS | 581,362 | 12.7M $ | 0.13 % | 0.55 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Small-Cap Value Fund, Inc. T. ROWE PRICE SMALL-CAP VALUE FUND, INC. | 561,374 | 12.2M $ | 0.13 % | 0.53 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap Growth ETF iShares Trust | 551,681 | 12M $ | 0.06 % | 0.52 % | as of Mar 31, 2026 ↗ |
| iShares S&P Small-Cap 600 Growth ETF iShares Trust | 551,392 | 12M $ | 0.18 % | 0.52 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 549,970 | 9.2M $ | 0.02 % | 0.52 % | as of Feb 28, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 521,760 | 10.9M $ | 1.25 % | 0.49 % | as of Apr 30, 2026 ↗ |
| Schwab U.S. Small-Cap ETF SCHWAB STRATEGIC TRUST | 510,017 | 8.5M $ | 0.04 % | 0.48 % | as of Feb 28, 2026 ↗ |
| iShares S&P Small-Cap 600 Value ETF iShares Trust | 401,485 | 8.7M $ | 0.12 % | 0.38 % | as of Mar 31, 2026 ↗ |
| iShares Russell Mid-Cap ETF iShares Trust | 377,907 | 8.2M $ | 0.02 % | 0.36 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Index Fund Fidelity Salem Street Trust | 366,388 | 7.7M $ | 0.02 % | 0.35 % | as of Apr 30, 2026 ↗ |
| VANGUARD S&P SMALL-CAP 600 INDEX FUND VANGUARD ADMIRAL FUNDS | 359,678 | 6M $ | 0.11 % | 0.34 % | as of Feb 28, 2026 ↗ |
| State Street(R) SPDR(R) S & P 600(TM) Small Cap Growth ETF SPDR SERIES TRUST | 337,206 | 7.3M $ | 0.18 % | 0.32 % | as of Mar 31, 2026 ↗ |
| iShares Russell 1000 Growth ETF iShares Trust | 335,017 | 7.3M $ | 0.01 % | 0.32 % | as of Mar 31, 2026 ↗ |
| VANGUARD EXPLORER FUND VANGUARD EXPLORER FUND | 329,261 | 6.9M $ | 0.03 % | 0.31 % | as of Apr 30, 2026 ↗ |
| VANGUARD HEALTH CARE INDEX FUND VANGUARD WORLD FUND | 299,230 | 5M $ | 0.02 % | 0.28 % | as of Feb 28, 2026 ↗ |
| AQR Long-Short Equity Fund AQR Funds | 279,114 | 6.1M $ | 0.08 % | 0.26 % | as of Mar 31, 2026 ↗ |
| AQR Equity Market Neutral Fund AQR Funds | 268,422 | 5.8M $ | 0.18 % | 0.25 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S & P 600(TM) Small Cap Value ETF SPDR SERIES TRUST | 221,169 | 4.8M $ | 0.12 % | 0.21 % | as of Mar 31, 2026 ↗ |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 195,648 | 3.3M $ | 0.00 % | 0.19 % | as of Feb 28, 2026 ↗ |
| VANGUARD STRATEGIC SMALL-CAP EQUITY FUND VANGUARD HORIZON FUNDS | 178,452 | 3.9M $ | 0.16 % | 0.17 % | as of Mar 31, 2026 ↗ |
| Direxion Daily S&P Biotech Bull 3X Shares Direxion Shares ETF Trust | 175,121 | 3.7M $ | 0.70 % | 0.17 % | as of Apr 30, 2026 ↗ |
| Columbia Small Cap Index Fund COLUMBIA FUNDS SERIES TRUST | 166,793 | 2.8M $ | 0.11 % | 0.16 % | as of Feb 28, 2026 ↗ |
| WisdomTree U.S. SmallCap Fund WisdomTree Trust | 162,745 | 3.5M $ | 0.56 % | 0.15 % | as of Mar 31, 2026 ↗ |
| JNL Small Cap Index Fund JNL Series Trust | 161,478 | 3.5M $ | 0.15 % | 0.15 % | as of Mar 31, 2026 ↗ |
| Mid-Cap Growth Portfolio PACIFIC SELECT FUND | 161,341 | 3.5M $ | 0.46 % | 0.15 % | as of Mar 31, 2026 ↗ |
| State Street(R) SPDR(R) S&P Kensho New Economies Composite ETF SPDR SERIES TRUST | 160,624 | 3.5M $ | 0.15 % | 0.15 % | as of Mar 31, 2026 ↗ |
| First Trust Small Cap Growth AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 157,956 | 3.3M $ | 0.32 % | 0.15 % | as of Apr 30, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 154,487 | 2.6M $ | 0.00 % | 0.15 % | as of Feb 28, 2026 ↗ |
| Hotchkis and Wiley Small Cap Diversified Value Fund HOTCHKIS & WILEY FUNDS/DE/ | 143,400 | 3.1M $ | 0.38 % | 0.14 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage Small Cap Core Fund BlackRock Funds | 137,262 | 2.3M $ | 0.05 % | 0.13 % | as of Feb 27, 2026 ↗ |
| iShares Core S&P Total U.S. Stock Market ETF iShares Trust | 137,154 | 3M $ | 0.00 % | 0.13 % | as of Mar 31, 2026 ↗ |
| VANGUARD RUSSELL 1000 GROWTH INDEX FUND VANGUARD SCOTTSDALE FUNDS | 127,175 | 2.1M $ | 0.00 % | 0.12 % | as of Feb 28, 2026 ↗ |
| Invesco S&P SmallCap 600 Revenue ETF Invesco Exchange-Traded Fund Trust II | 124,201 | 2.1M $ | 0.12 % | 0.12 % | as of Feb 28, 2026 ↗ |
| AQR Managed Futures Strategy Fund AQR Funds | 122,615 | 2.7M $ | 0.09 % | 0.12 % | as of Mar 31, 2026 ↗ |
| AQR Managed Futures Strategy HV Fund AQR Funds | 118,342 | 2.6M $ | 0.21 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Large Cap Growth Index Fund Fidelity Salem Street Trust | 116,915 | 2.4M $ | 0.01 % | 0.11 % | as of Apr 30, 2026 ↗ |
| Federated Hermes MDT Market Neutral Fund Federated Hermes Adviser Series | 114,447 | 2.5M $ | 0.11 % | 0.11 % | as of Mar 31, 2026 ↗ |
| Fidelity Mid Cap Growth Index Fund Fidelity Salem Street Trust | 100,528 | 2.2M $ | 0.06 % | 0.10 % | as of Mar 31, 2026 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 93,395 | 1.6M $ | 1.13 % | 0.09 % | as of Feb 28, 2026 ↗ |
| PSF Small-Cap Stock Index Portfolio Prudential Series Fund | 90,500 | 2M $ | 0.15 % | 0.09 % | as of Mar 31, 2026 ↗ |
| VANGUARD S&P SMALL-CAP 600 VALUE INDEX FUND VANGUARD ADMIRAL FUNDS | 89,895 | 1.5M $ | 0.09 % | 0.09 % | as of Feb 28, 2026 ↗ |
| U.S. MICRO CAP PORTFOLIO DFA INVESTMENT DIMENSIONS GROUP INC | 89,840 | 1.9M $ | 0.03 % | 0.09 % | as of Apr 30, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 87,227 | 1.5M $ | 1.05 % | 0.08 % | as of Feb 28, 2026 ↗ |
| Dimensional U.S. Small Cap ETF Dimensional ETF Trust | 87,059 | 1.8M $ | 0.01 % | 0.08 % | as of Apr 30, 2026 ↗ |
| SmallCap Value Fund II Principal Funds, Inc | 86,800 | 1.8M $ | 0.15 % | 0.08 % | as of Apr 30, 2026 ↗ |
| VANGUARD U.S. VALUE FACTOR ETF VANGUARD WELLINGTON FUND | 83,991 | 1.4M $ | 0.18 % | 0.08 % | as of Feb 28, 2026 ↗ |
| SmallCap S&P 600 Index Fund Principal Funds, Inc | 82,365 | 1.7M $ | 0.13 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 80,577 | 1.7M $ | 1.07 % | 0.08 % | as of Apr 30, 2026 ↗ |
| VANGUARD TOTAL WORLD STOCK INDEX FUND VANGUARD INTERNATIONAL EQUITY INDEX FUNDS | 80,332 | 1.7M $ | 0.00 % | 0.08 % | as of Apr 30, 2026 ↗ |
| Nuveen Equity Index Fund TIAA-CREF Funds | 78,617 | 1.6M $ | 0.00 % | 0.07 % | as of Apr 30, 2026 ↗ |
| Small Cap Value Portfolio NORTHWESTERN MUTUAL SERIES FUND INC | 76,185 | 1.7M $ | 0.28 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Empower S&P Small Cap 600 Index Fund EMPOWER FUNDS, INC. | 74,235 | 1.6M $ | 0.15 % | 0.07 % | as of Mar 31, 2026 ↗ |
| Strategic Advisers U.S. Total Stock Fund Fidelity Rutland Square Trust II | 71,934 | 1.2M $ | 0.00 % | 0.07 % | as of Feb 28, 2026 ↗ |
| VANGUARD S&P SMALL-CAP 600 GROWTH INDEX FUND VANGUARD ADMIRAL FUNDS | 71,345 | 1.2M $ | 0.13 % | 0.07 % | as of Feb 28, 2026 ↗ |
| THRIVENT SMALL CAP INDEX PORTFOLIO Thrivent Series Fund, Inc. | 69,943 | 1.5M $ | 0.15 % | 0.07 % | as of Mar 31, 2026 ↗ |
| VANGUARD TAX-MANAGED CAPITAL APPRECIATION FUND VANGUARD TAX-MANAGED FUNDS | 65,541 | 1.4M $ | 0.01 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab Total Stock Market Index Fund SCHWAB CAPITAL TRUST | 65,417 | 1.4M $ | 0.00 % | 0.06 % | as of Apr 30, 2026 ↗ |
| iShares Russell 1000 ETF iShares Trust | 64,897 | 1.4M $ | 0.00 % | 0.06 % | as of Mar 31, 2026 ↗ |
| First Trust Small Cap Core AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 63,641 | 1.3M $ | 0.11 % | 0.06 % | as of Apr 30, 2026 ↗ |
| AST Small-Cap Equity Portfolio Advanced Series Trust | 63,556 | 1.4M $ | 0.07 % | 0.06 % | as of Mar 31, 2026 ↗ |
| Schwab U.S. Broad Market ETF SCHWAB STRATEGIC TRUST | 63,450 | 1.1M $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 61,227 | 1M $ | 0.00 % | 0.06 % | as of Feb 28, 2026 ↗ |
| iShares ESG Aware MSCI USA Small-Cap ETF iShares Trust | 60,081 | 1M $ | 0.04 % | 0.06 % | as of Feb 28, 2026 ↗ |
| VANGUARD BALANCED INDEX FUND VANGUARD VALLEY FORGE FUNDS | 57,849 | 1.3M $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Large Cap Index Master Portfolio Master Investment Portfolio | 55,854 | 1.2M $ | 0.00 % | 0.05 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Total Market Index Fund Fidelity Concord Street Trust | 54,609 | 1.1M $ | 0.00 % | 0.05 % | as of Apr 30, 2026 ↗ |
| BIOTECHNOLOGY ULTRASECTOR PROFUND ProFunds | 54,198 | 1.1M $ | 0.62 % | 0.05 % | as of Apr 30, 2026 ↗ |
| Multi-Manager Small Cap Equity Strategies Fund COLUMBIA FUNDS SERIES TRUST I | 52,100 | 873.2K $ | 0.07 % | 0.05 % | as of Feb 28, 2026 ↗ |
| Invesco RAFI US 1000 ETF Invesco Exchange-Traded Fund Trust | 52,094 | 1.1M $ | 0.01 % | 0.05 % | as of Apr 30, 2026 ↗ |
| BNY Mellon Smallcap Stock Index Fund BNY MELLON INDEX FUNDS, INC. | 52,011 | 1.1M $ | 0.13 % | 0.05 % | as of Apr 30, 2026 ↗ |
| iShares U.S. Healthcare ETF iShares Trust | 50,461 | 1.1M $ | 0.04 % | 0.05 % | as of Apr 30, 2026 ↗ |
| SIMT Large Cap Growth Fund SEI INSTITUTIONAL MANAGED TRUST | 48,998 | 1.1M $ | 0.08 % | 0.05 % | as of Mar 31, 2026 ↗ |
| JPMorgan Small & Mid Cap Enhanced Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 47,062 | 1M $ | 0.04 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD MARKET NEUTRAL FUND VANGUARD MONTGOMERY FUNDS | 46,642 | 1M $ | 0.24 % | 0.04 % | as of Mar 31, 2026 ↗ |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 46,211 | 1M $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| BlackRock Advantage SMID Cap Fund, Inc. BlackRock Advantage SMID Cap Fund, Inc. | 45,726 | 995K $ | 0.13 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Fidelity MSCI Health Care Index ETF FIDELITY COVINGTON TRUST | 45,547 | 951K $ | 0.03 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 43,955 | 917.8K $ | 1.55 % | 0.04 % | as of Apr 30, 2026 ↗ |
| Avantis U.S. Small Cap Equity ETF American Century ETF Trust | 43,867 | 735.2K $ | 0.03 % | 0.04 % | as of Feb 28, 2026 ↗ |
| SMALL COMPANY GROWTH PORTFOLIO VANGUARD VARIABLE INSURANCE FUNDS | 43,489 | 946.3K $ | 0.07 % | 0.04 % | as of Mar 31, 2026 ↗ |
| College Retirement Equities Fund - Total Global Stock Account College Retirement Equities Fund | 41,847 | 910.6K $ | 0.00 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 40,976 | 686.8K $ | 1.31 % | 0.04 % | as of Feb 28, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 40,226 | 875.3K $ | 0.65 % | 0.04 % | as of Mar 31, 2026 ↗ |
| Nuveen Large Cap Growth Index Fund TIAA-CREF Funds | 39,803 | 831.1K $ | 0.00 % | 0.04 % | as of Apr 30, 2026 ↗ |
| JPMorgan BetaBuilders U.S. Small Cap Equity ETF J.P. Morgan Exchange-Traded Fund Trust | 39,075 | 815.9K $ | 0.11 % | 0.04 % | as of Apr 30, 2026 ↗ |
| AQR Multi-Asset Fund AQR Funds | 38,676 | 841.6K $ | 0.04 % | 0.04 % | as of Mar 31, 2026 ↗ |
| iShares Russell 2500 ETF iShares Trust | 36,741 | 799.5K $ | 0.03 % | 0.03 % | as of Mar 31, 2026 ↗ |
| Fidelity ZERO Extended Market Index Fund Fidelity Concord Street Trust | 36,714 | 766.6K $ | 0.03 % | 0.03 % | as of Apr 30, 2026 ↗ |
| Small Cap Stock Index Portfolio BNY MELLON INVESTMENT PORTFOLIOS | 36,670 | 797.9K $ | 0.15 % | 0.03 % | as of Mar 31, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table counts shares; this one measures what the company weighs inside each fund.
| Fund | Weight in fund | |
|---|---|---|
| TRUVI VALUE FI GESIURIS ASSET MANAGEMENT, SGIIC, S.A. | 3.42 % | as of Dec 31, 2025 ↗ |
| First Trust NYSE Arca Biotechnology Index Fund First Trust Exchange-Traded Fund | 3.24 % | as of Mar 31, 2026 ↗ |
| iShares Neuroscience and Healthcare ETF iShares Trust | 2.21 % | as of Apr 30, 2026 ↗ |
| Virtus Biotech Etf ETFis Series Trust I | 1.55 % | as of Apr 30, 2026 ↗ |
| Global X Genomics & Biotechnology ETF GLOBAL X FUNDS | 1.31 % | as of Feb 28, 2026 ↗ |
| First Trust Health Care AlphaDEX Fund First Trust Exchange-Traded AlphaDEX Fund | 1.25 % | as of Apr 30, 2026 ↗ |
| LAGO ERIE, SICAV, S.A. GESALCALA, S.A., S.G.I.I.C. | 1.14 % | as of Dec 31, 2025 ↗ |
| ALPS Medical Breakthroughs ETF ALPS ETF TRUST | 1.13 % | as of Feb 28, 2026 ↗ |
| Harbor Human Capital Factor US Small Cap ETF Harbor ETF Trust | 1.07 % | as of Apr 30, 2026 ↗ |
| Invesco S&P SmallCap Health Care ETF Invesco Exchange-Traded Fund Trust II | 1.05 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each SEC quarterly data set, newest first. The change is read against the quarter before it.
| Quarter | Shareholders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 266 | +6 | 38,989,939 | +8.7 % |
| 2026Q1 | 260 | -10 | 35,878,884 | +12.4 % |
| 2025Q4 | 270 | -52 | 31,920,416 | +19.9 % |
| 2025Q3 | 322 | -63 | 26,631,997 | -33.8 % |
| 2025Q2 | 385 | -63 | 40,206,470 | -1.6 % |
| 2025Q1 | 448 | -32 | 40,842,759 | +0.5 % |
| 2024Q4 | 480 | +6 | 40,621,064 | +6.0 % |
| 2024Q3 | 474 | +50 | 38,313,109 | +12.2 % |
| 2024Q2 | 424 | +26 | 34,146,551 | +3.0 % |
| 2024Q1 | 398 | -64 | 33,141,049 | -11.9 % |
| 2023Q4 | 462 | 37,623,800 |
Institutional managers
330 managers declare this company to the SEC (Form 13F); the 25 largest follow.
| Manager | Shares | Value | |
|---|---|---|---|
| BlackRock, Inc. | 14,755,277 | 321.1M $ | as of Mar 31, 2026 |
| STATE STREET CORP | 6,613,314 | 143.9M $ | as of Mar 31, 2026 |
| AQR CAPITAL MANAGEMENT LLC | 6,433,112 | 138.6M $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 4,593,195 | 99.9M $ | as of Mar 31, 2026 |
| FIRST TRUST ADVISORS LP | 4,135,788 | 90M $ | as of Mar 31, 2026 |
| RA CAPITAL MANAGEMENT, L.P. | 3,902,596 | 84.9M $ | as of Mar 31, 2026 |
| Erste Asset Management GmbH | 2,968,945 | 61.3M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 2,596,993 | 56.5M $ | as of Mar 31, 2026 |
| Aberdeen Group plc | 2,318,890 | 50.5M $ | as of Mar 31, 2026 |
| UBS Group AG | 2,232,459 | 48.6M $ | as of Mar 31, 2026 |
| BANK OF AMERICA CORP /DE/ | 2,145,926 | 46.7M $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 1,988,796 | 43.3M $ | as of Mar 31, 2026 |
| FEDERATED HERMES, INC. | 1,786,021 | 38.9M $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 1,665,078 | 36.2M $ | as of Mar 31, 2026 |
| CANADA PENSION PLAN INVESTMENT BOARD | 1,242,800 | 27M $ | as of Mar 31, 2026 |
| MILLENNIUM MANAGEMENT LLC | 1,221,682 | 26.6M $ | as of Mar 31, 2026 |
| CITIGROUP INC | 1,147,648 | 25M $ | as of Mar 31, 2026 |
| T. Rowe Price Investment Management, Inc. | 1,133,308 | 24.7K $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 1,078,252 | 23.5M $ | as of Mar 31, 2026 |
| Connor, Clark & Lunn Investment Management Ltd. | 1,019,951 | 22.2M $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 897,532 | 19.5M $ | as of Mar 31, 2026 |
| Legal & General Group Plc | 866,743 | 18.9M $ | as of Mar 31, 2026 |
| Voleon Capital Management LP | 800,660 | 17.4M $ | as of Mar 31, 2026 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 791,129 | 17.2M $ | as of Mar 31, 2026 |
| 683 Capital Management, LLC | 750,000 | 16.3M $ | as of Mar 31, 2026 |
Declared shareholders of Sarepta Therapeutics Inc
2 beneficial ownership filings. These stakes do not add up: an asset manager filing aggregates its own funds, already counted above.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Vanguard Portfolio Management | 6.43 % | 6,751,168 | as of Mar 31, 2026 · SCHEDULE 13G |
| Vanguard Capital Management | 5.11 % | 5,369,116 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Sarepta Therapeutics Inc
14 funds declare 16 bond lines of this company. The amount is the one filed, never a share of the debt: no regulator publishes the amount outstanding in open access.
| Fund | Bond lines | Value | |
|---|---|---|---|
| Calamos Market Neutral Income Fund | 1 | 13.9M $ | as of Apr 30, 2026 |
| iShares Convertible Bond ETF | 1 | 12M $ | as of Apr 30, 2026 |
| State Street(R) SPDR(R) Bloomberg Convertible Securities ETF | 1 | 9.4M $ | as of Mar 31, 2026 |
| AQR Diversified Arbitrage Fund | 1 | 7.1M $ | as of Mar 31, 2026 |
| Fidelity Convertible Securities Fund | 2 | 3.5M $ | as of Feb 28, 2026 |
| Fidelity Strategic Dividend and Income Fund | 2 | 1.4M $ | as of Feb 28, 2026 |
| Greenspring Income Opportunities Fund | 1 | 1.1M $ | as of Mar 31, 2026 |
| Simplify Opportunistic Income ETF | 1 | 838.8K $ | as of Mar 31, 2026 |
| TETON Convertible Securities Fund | 1 | 167.8K $ | as of Mar 31, 2026 |
| JNL Multi-Manager Alternative Fund | 1 | 161K $ | as of Mar 31, 2026 |
| 1290 VT Convertible Securities Portfolio | 1 | 125.1K $ | as of Mar 31, 2026 |
| Harbor Ares Systematic Convertible Securities Fund | 1 | 86.2K $ | as of Apr 30, 2026 |
| Lazard Enhanced Opportunities Portfolio | 1 | 80.5K $ | as of Mar 31, 2026 |
| PACE Alternative Strategies Investments | 1 | 25.7K $ | as of Apr 30, 2026 |
Cite this page
Titelia. "Fund shareholders of Sarepta Therapeutics Inc". https://titelia.com/en/stocks/sarepta-therapeutics-inc-US8036071004